Related Experiment Video
Updated: Apr 21, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Genomic analysis of the interleukin-1β-511 and interleukin-6-174 gene polymorphisms in Turkish patients with epilepsy
I Gök1, V Esen2, H Kose Ozlece3
1Department of Bioengineering, Faculty of Engineering & Architecture, Kafkas University, Kars, Turkey dnzgoki@gmail.com.
Abstract:
In this study, we examined the frequency of polymorphisms in the interleukin (IL) genes IL-1β-511 and IL-6-174 in patients with epilepsy as well as a control group in Kars, Turkey. A total of 100 patients diagnosed with epilepsy and 100 nonepileptic subjects as a control group were examined. Peripheral blood samples were acquired from patients and control subjects for DNA extraction. The target region was amplified using polymerase chain reaction and digested using the restriction enzymes SfaNI and AvaI. Restriction products were extracted from agarose gel electrophoresis and polymorphisms were analyzed using gel images. For IL-1β, the most common genotype among the epilepsy group was the CT genotype with a 62% frequency; the T allele was the most common allele with a frequency of 34%. Among the control group, however, the CT genotype showed a frequency of 25% and the T allele had a 22% frequency. For IL-6-174, among the epilepsy group, the GG genotype prevalence was approximately 42% and G allele prevalence was 46%. The GG genotype was approximately 50% and the G allele was 53% in the control group. Thus, changes in the allele frequency of the T allele of IL-1β-174 may be associated with epilepsy. However, there was no significant difference for the G allele frequency of IL-6-511. A larger sample size should be examined to verify these relationships, which could help to improve the clinical diagnosis and treatment of epilepsy.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Metabolism: Overview